Detection of circulating tumor DNA in patients with osteosarcoma

Identification and quantification of somatic alterations in plasma-derived, circulating tumor DNA (ctDNA) is gaining traction as a non-invasive and cost effective method of disease monitoring in cancer patients, particularly to evaluate response to treatment and monitor for disease recurrence. To ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Barris, David M., Weiner, Shoshana B., Dubin, Robert A., Fremed, Michael, Zhang, Xusheng, Piperdi, Sajida, Zhang, Wendong, Maqbool, Shahina, Gill, Jonathan, Roth, Michael, Hoang, Bang, Geller, David, Gorlick, Richard, Weiser, Daniel A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2018
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849166/
https://ncbi.nlm.nih.gov/pubmed/29560102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24268
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge